Diligence memo · auto-generated · as of July 2, 2026
Vistim Labs Inc.
Vistim Labs Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Vistim Labs Inc. operates in Biotechnology, based in Claymont.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Vistim Labs Inc. has raised $932K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $807K on 2022-12-19.
Most recent recorded round closed around 2024-09-16.
Valuation (modeled)modeled
Provath models Vistim Labs Inc. at approximately $506K (range $67K–$1.6M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.16× the median modeled value of Pre-Seed Biotechnology companies in 2022–2024 (185 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 5 months.
Last raise 21 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 4.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 17% of Biotechnology peers (4293 compared).
Modeled value ranks above 1% of those peers.
Closest niche peers: TissueMill Technologies LLC, Aldebaran Therapeutics, Inc., BullFrog AI Holdings, Inc., Vesicle Therapeutics Inc., TAUC3 Biologics Ltd.
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.